Bethan Sarah Woods

University of York

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Pharmacy Pharmacy professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Mark Sculpher

University of York

UNITED KINGDOM

View details

Zosia Miedzybrodzka

University of Aberdeen

UNITED KINGDOM

View details

Marta Ferreira Oliveira Soares

Professor

University of York Environment Department

UNITED KINGDOM

View details

Abigail Colson

University Of Strathclyde

UNITED KINGDOM

View details

Stephen Weng

Assistant Professor

University of Nottingham

UNITED KINGDOM

View details

Barbara Iyen

NIHR Clinical Assistant Professor/ Academic clinical lecturer

University of Nottingham

UNITED KINGDOM

View details

helen weatherly

Professor

University of York

UNITED KINGDOM

View details

Alison Scope

Sheffield Hallam University

UNITED KINGDOM

View details

Nadeem Qureshi

Clinical Professor

University of Nottingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bethan Sarah Woods

Research Interests

Explore related searches

Contact this professor

Articles (10)

Challenges and opportunities for identifying people with Familial Hypercholesterolaemia in the UK: Evidence from the National FH PASS database

Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required

Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis

How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysis.

Classifying information-sharing methods.

Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?

Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems.

Concomitant health benefits package design and research prioritisation: development of a new approach and an application to Malawi.

Partitioned Survival and State Transition Models for Healthcare Decision Making in Oncology: Where Are We Now?

Collaborators (9)

Mark Sculpher

Zosia Miedzybrodzka

Marta Ferreira Oliveira Soares

Abigail Colson

Stephen Weng

Barbara Iyen

helen weatherly

Alison Scope

Nadeem Qureshi

Make your next move.